At ESC Congress 2023 we will be 'joining forces to protect the heart' and create the future of cardiology – a future where everything is possible.

Dr Jorg Taubel will be attending in person along with Dr Julian Gilmore from the Royal Free London NHS Foundation Trust who will be presenting ‘ATTRibute-CM: acoramidis (AG10) in patients with transthyretin amyloid cardiomyopathy’ 

Latest news

Richmond Pharmacology Appoints John Hotti as Chief Technology Officer

April 22, 2026
Richmond Pharmacology is pleased to announce the appointment of John Hotti as Chief Technology Officer (CTO), strengthening the company’s leadership in technology-enabled clinical research.
Read more

Events

Clinical Trials Innovation Programme

10 - 11 February 2026
Richmond Pharmacology is pleased to attend the Clinical Trials Innovation Programme Conference in Nice, France, 10–11 February 2026.
View event